Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/13/2025
Kelun-Biotech Wins China Approval for TROP2 ADC in EGFR-Mutant NSCLC A...
10/13/2025
Micot Pharma Completes Over CNY 200M Series D Financing, Advances Towa...
10/13/2025
Walgreens Boots Alliance Fully Exits Nanjing Pharma
10/13/2025
Hope Medicine Reports Positive Global Phase 2 Results for HMI-115
10/13/2025
China Introduces New Regulations to Govern Clinical Research and Appli...
10/13/2025
Hansoh Pharma Reports Phase II Data for Oral B7H3 ADC HS-20093
10/13/2025
Lepu Reports Early Clinical Data for ADC Programs in Various Cancers
10/13/2025
U.S. Senate Approves Revised China Biotech Competition Bill with Softe...
10/8/2025
China Biopharma Financing Rebounds in September as IPO Pipeline Surges
10/8/2025
License-Out Deals in China Drop Sharply in September Amid Steady Deal ...
10/8/2025
Only Two Novel Drugs Win China Approval in September as Local Innovati...
10/3/2025
Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242
10/3/2025
Santen and RemeGen Files Chinese BLA for RC28-E
10/1/2025
China Rolls Out 2025 Pharmacopoeia to Sharpen Drug Oversight
9/30/2025
China's Biopharma Sector Sees Surge in IPO Activity on HKEX and SSE
9/30/2025
China Issues Detailed Rules on Pre-Approval Import of Overseas Drugs
9/30/2025
Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff ...
9/29/2025
Novatim Strikes Licensing Deal for Dual-Target CAR-T Therapy as China ...
9/29/2025
China Eliminates 30% Import Duty on Indian Drugs Amid Global Trade Shi...
9/26/2025
China's Innovative Drug Market Shows Diverging Trends Between Hospital...
9/26/2025
Recent Official and Executive Moves
9/25/2025
SystImmune to Unveil New Clinical Data on Two ADC Programs at ESMO 202...
9/24/2025
Hengrui's ADC SHR-A181 Lands $1.1B Licensing Deal with Glenmark
9/24/2025
NMPA Accepts Alphamab's NDA for HER2 BsAb in Gastric Cancer
9/23/2025
KeyMed Initiates First Phase 3 Trial for CD3/BCMA BsAb CM336
9/23/2025
MicuRx Plans Private Placement to Raise Up to ¥1B
9/23/2025
Innovent's Weight-Loss Drug Challenges Western Giants in China's Obesi...
9/23/2025
China Unveils New Rules for 11th Round of National Centralized Drug VB...
9/23/2025
CMS and Generix Join Forces for Innovative Biologics
9/23/2025
China's Edge over U.S. Biotech Was Never Scientific (Washington Post)
Page:
1
/
368
Total number of articles:
11038
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit